- Email: [email protected]
Corrigendum to “Clinical and genetic studies in patients with Lafora disease from Pakistan”[J. Neurol. Sci. 373 (2017) 263–267]
Journal of the Neurological Sciences 375 (2017) 281
Contents lists available at ScienceDirect
Journal of the Neurological Sciences journal homepage: www.elsevier.com/locate/jns
Corrigendum
Corrigendum to “Clinical and genetic studies in patients with Lafora disease from Pakistan” [J. Neurol. Sci. 373 (2017) 263–267] Arsalan Ahmad a,1, Rubina Dad b,1, Muhammad Ikram Ullah c, Tahir Ahmed Baig b, Imran N. Ahmad d, Abdul Nasir e, Christian A. Hübner f, Muhammad Jawad Hassan b,⁎ a
Division of Neurology, Shifa International Hospital, Shifa Tameer e Millat University, Islamabad, Pakistan Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences & Technology (NUST), Islamabad, Pakistan c Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan d Division of Pathology, Shifa International Hospital, Shifa Tameer e Millat University, Islamabad, Pakistan e Department of Biochemistry, Abdul Wali Khan University Mardan, Pakistan f Institute of Human Genetics, University of Jena, Kollegiengasse 10, D-07743 Jena, Germany b
The authors regret that there were mistakes in the published version of this paper. These mistakes and their correction are detailed below: Published: Ahmad et al., 2017 clinical short communication, JNS15072, entitled, “Clinical and genetic studies in patients with Lafora disease from Pakistan” Volume 373, 15 February 2017, Pages 263–267. 4. Discussion Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8% in general population while in developing countries a higher burden of this disease is found with rate of prevalence between 10 and 40% [22, 23]. Similarly, in Pakistan prevalence is presumed to be high but no data is available. Corrected: Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like
DOI of original article: http://dx.doi.org/10.1016/j.jns.2017.01.010. ⁎ Corresponding author at: Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences & Technology (NUST), Sector H-12, Islamabad 44000, Pakistan. E-mail address: [email protected] (M.J. Hassan). 1 These authors contributed equally to this work, so both will be considered as first author.
http://dx.doi.org/10.1016/j.jns.2017.02.010
abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8–10/1000 in general population while in developing countries a higher burden of this disease is found [22, 23]. A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]. [27] Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958. Key: 1- “8%” was changed to 8/1000. 2- “with rate of prevalence between 10 and 40%” was deleted. 3- “Similarly, in Pakistan prevalence is presumed to be high but no data is available” was changed to “A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]”. 4- Reference was added “Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958”.
Contents lists available at ScienceDirect
Journal of the Neurological Sciences journal homepage: www.elsevier.com/locate/jns
Corrigendum
Corrigendum to “Clinical and genetic studies in patients with Lafora disease from Pakistan” [J. Neurol. Sci. 373 (2017) 263–267] Arsalan Ahmad a,1, Rubina Dad b,1, Muhammad Ikram Ullah c, Tahir Ahmed Baig b, Imran N. Ahmad d, Abdul Nasir e, Christian A. Hübner f, Muhammad Jawad Hassan b,⁎ a
Division of Neurology, Shifa International Hospital, Shifa Tameer e Millat University, Islamabad, Pakistan Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences & Technology (NUST), Islamabad, Pakistan c Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan d Division of Pathology, Shifa International Hospital, Shifa Tameer e Millat University, Islamabad, Pakistan e Department of Biochemistry, Abdul Wali Khan University Mardan, Pakistan f Institute of Human Genetics, University of Jena, Kollegiengasse 10, D-07743 Jena, Germany b
The authors regret that there were mistakes in the published version of this paper. These mistakes and their correction are detailed below: Published: Ahmad et al., 2017 clinical short communication, JNS15072, entitled, “Clinical and genetic studies in patients with Lafora disease from Pakistan” Volume 373, 15 February 2017, Pages 263–267. 4. Discussion Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8% in general population while in developing countries a higher burden of this disease is found with rate of prevalence between 10 and 40% [22, 23]. Similarly, in Pakistan prevalence is presumed to be high but no data is available. Corrected: Lafora disease is one of the rare neuro-developmental diseases of early adolescent. It is presented with diverse clinical features like
DOI of original article: http://dx.doi.org/10.1016/j.jns.2017.01.010. ⁎ Corresponding author at: Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences & Technology (NUST), Sector H-12, Islamabad 44000, Pakistan. E-mail address: [email protected] (M.J. Hassan). 1 These authors contributed equally to this work, so both will be considered as first author.
http://dx.doi.org/10.1016/j.jns.2017.02.010
abnormal social interactions, continuous seizures, ataxia and intellectual disability, decline of neuronal functions and loss of motor movements at later stages of the disease [21]. Worldwide, the approximate prevalence of epilepsy is 8–10/1000 in general population while in developing countries a higher burden of this disease is found [22, 23]. A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]. [27] Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958. Key: 1- “8%” was changed to 8/1000. 2- “with rate of prevalence between 10 and 40%” was deleted. 3- “Similarly, in Pakistan prevalence is presumed to be high but no data is available” was changed to “A study from southern Pakistan indicates an age-specific prevalence rate of 9.99/1000 (14.8/1000 in rural and 7.4/1000 in urban areas) for recurrent, non-febrile, active epilepsy [27]”. 4- Reference was added “Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia, 1994; 35(5):950–958”.